USA Swimming Sheds Light On Process That Led To New Transgender Policy
USA Swimming has shared the steps it took in developing its new transgender policy, which was published at the beginning of February.
Month: March 2022
Merck’s KEYTRUDA® (pembrolizumab) Demonstrated Significant Improvement in Distant Metastasis-Free Survival (DMFS) Compared to Placebo as Adjuvant Therapy for Patients With Resected Stage IIB and IIC Melanoma in Phase 3 KEYNOTE-716 Trial
Merck’s KEYTRUDA Demonstrated Significant Improvement in Distant Metastasis-Free Survival in Stage IIB and IIC Melanoma in KEYNOTE-716 Trial
Astellas’ eyes filings for menopause drug fezolinetant after ph3 win –
Astellas looks to be in pole position to bring a new non-hormonal therapy for symptoms of menopause to
[Special Interview] Bayer, strong in CV, female health areas, is trailblazer in cell and gene fields, too
![[Special Interview] Bayer, strong in CV, female health areas, is trailblazer in cell and gene fields, too](http://cdn.koreabiomed.com/news/thumbnail/202203/13240_13731_1232_v150.jpg "[Special Interview] Bayer, strong in CV, female health areas, is trailblazer in cell and gene fields, too")
Bayer, long a household word in cardiovascular diseases and women’s health, is distinguishing itself in new blockbuster candidates and novel platforms while adding to its traditional strength.For instance, the global pharmaceutical giant is undergoing …
Merck’s KEYTRUDA® (pembrolizumab) Demonstrated Significant Improvement in Distant Metastasis-Free Survival (DMFS) Compared to Placebo as Adjuvant Therapy for Patients With Resected Stage IIB and IIC Melanoma in Phase 3 KEYNOTE-716 Trial
Merck’s KEYTRUDA ® (pembrolizumab) Demonstrated Significant Improvement in Distant Metastasis-Free Survival (DMFS) Compared to Placebo as Adjuvant Therapy for Patients With Resected Stage IIB and IIC Melanoma in Phase 3 KEYNOTE-716 Trial.
VIP Total Health & Hydration, a leader in Hormone Replacement Therapy in Texas, announces new provider status with Biote
When it comes to bioidentical hormone replacement therapy (BHRT), the Biote Method is the preferred choice among more than 4,800+ physicians.
Early Menopause May Raise a Woman’s Odds for Dementia
TUESDAY, March 1, 2022 (HealthDay News) — Women who enter menopause early may be more likely to develop dementia later in life, new research indicates.
Early Menopause May Raise a Woman’s Odds for Dementia
TUESDAY, March 1, 2022 (HealthDay News) — Women who enter menopause early may be more likely to develop dementia later in life, new research indicates.
DR ELLIE CANNON: Since my GP took me off HRT my life is hell
DR ELLIE CANNON: Today’s reader wants to know whether it is possible to resume hormone replacement therapy as she is suffering many symptoms of the menopause.
5 Common Signs Of Male Menopause
“Male menopause” is a more well-known term for andropause, and that encompasses age-related changes in hormone levels among men.